Exchange: NASDAQ Sector: Healthcare Industry: Health Information Services
3.75% $3.32
America/New_York / 28 mar 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 102.84 mill |
EPS: | -0.200 |
P/E: | -16.60 |
Earnings Date: | Mar 28, 2024 |
SharesOutstanding: | 30.98 mill |
Avg Daily Volume: | 0.0279 mill |
RATING 2024-03-28 |
---|
S- |
Strong Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Neutral | |
Return On Equity: | Strong Buy | |
Return On Asset: | Strong Buy | |
DE: | Strong Buy | |
P/E: | Strong Buy | |
Price To Book: | Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -16.60 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE -16.60 | industry: PE -4.88 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 3.11 - 3.53 ( +/- 6.27%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-27 | Adler Mark J Md | Buy | 15 000 | Stock Option (right to buy) |
2024-03-27 | Banwell Ian | Buy | 15 000 | Stock Option (right to buy) |
2024-03-27 | Vuori Kristiina Md | Buy | 15 000 | Stock Option (right to buy) |
2024-03-27 | Trotman Stanley S Jr | Buy | 15 000 | Stock Option (right to buy) |
2024-03-27 | Hajj Jennifer | Buy | 15 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
96.18 |
Last 99 transactions |
Buy: 2 767 669 | Sell: 68 057 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $3.32 (3.75% ) |
Volume | 0.0363 mill |
Avg. Vol. | 0.0279 mill |
% of Avg. Vol | 130.48 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Forian Inc. provides software solutions, proprietary data driven insights, and predictive analytics to optimize the operational, clinical, and financial performance of its healthcare, cannabis, and government customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides clients with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain; and STEMS, a seed-to-sale tracking module, to provide cannabis program management solution to cannabis regulatory agencies. In addition, the company offers security monitoring and web marketing services. The company is headquartered in Newtown, Pennsylvania.